112 related articles for article (PubMed ID: 2474512)
1. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by prostaglandin synthesis inhibition.
Weber F; Hempel K
Int Arch Allergy Appl Immunol; 1989; 89(2-3):242-5. PubMed ID: 2474512
[TBL] [Abstract][Full Text] [Related]
2. Protection against experimental allergic encephalomyelitis with complete Freund's adjuvant is unaffected by ionizing irradiation.
Weber F; Hempel K
Int Arch Allergy Appl Immunol; 1987; 83(2):174-7. PubMed ID: 2438218
[TBL] [Abstract][Full Text] [Related]
3. Unresponsiveness to experimental allergic encephalomyelitis in Lewis rats pretreated with complete Freund's adjuvant.
Hempel K; Freitag A; Freitag B; Endres B; Mai B; Liebaldt G
Int Arch Allergy Appl Immunol; 1985; 76(3):193-9. PubMed ID: 2579028
[TBL] [Abstract][Full Text] [Related]
4. Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats.
Willenborg DO; Higgins TJ
Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):135-41. PubMed ID: 6167253
[TBL] [Abstract][Full Text] [Related]
5. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
Englert D; Hempel K
Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
7. Experimental allergic encephalomyelitis-prophylactic and therapeutic treatment with the cyclooxygenase inhibitor piroxicam (Feldene).
Weber F; Meyermann R; Hempel K
Int Arch Allergy Appl Immunol; 1991; 95(2-3):136-41. PubMed ID: 1937915
[TBL] [Abstract][Full Text] [Related]
8. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
Waxman FJ; Taguiam JM; Whitacre CC
Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
[TBL] [Abstract][Full Text] [Related]
10. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
Frost H; Swanborg RH
Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
[TBL] [Abstract][Full Text] [Related]
12. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells.
Saoudi A; Simmonds S; Huitinga I; Mason D
J Exp Med; 1995 Aug; 182(2):335-44. PubMed ID: 7543135
[TBL] [Abstract][Full Text] [Related]
13. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
Bolton C; Allsopp G; Cuzner ML
Clin Exp Immunol; 1982 Jan; 47(1):127-32. PubMed ID: 6178543
[TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
15. Studies of V beta 8 T cell receptor peptide treatment in experimental autoimmune encephalomyelitis.
Stevens DB; Karpus WJ; Gould KE; Swanborg RH
J Neuroimmunol; 1992 Mar; 37(1-2):123-9. PubMed ID: 1372325
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tumor necrosis factor is protective against neurologic dysfunction after active immunization of Lewis rats with myelin basic protein.
Martin D; Near SL; Bendele A; Russell DA
Exp Neurol; 1995 Feb; 131(2):221-8. PubMed ID: 7534720
[TBL] [Abstract][Full Text] [Related]
17. Correlation between MRI and clinico-pathological manifestations in Lewis rats protected from experimental allergic encephalomyelitis by acylated synthetic peptide of myelin basic protein.
Karlik SJ; Munoz D; St Louis J; Strejan G
Magn Reson Imaging; 1999 Jun; 17(5):731-7. PubMed ID: 10372527
[TBL] [Abstract][Full Text] [Related]
18. Suppression of experimental allergic encephalomyelitis by alpha 2-macroglobulin.
Hunter N; Weston KM; Bowern NA
Immunology; 1991 May; 73(1):58-63. PubMed ID: 1710603
[TBL] [Abstract][Full Text] [Related]
19. Nasal administration of multiple antigens suppresses experimental autoimmune myasthenia gravis, encephalomyelitis and neuritis.
Shi FD; Bai XF; Xiao BG; van der Meide PH; Link H
J Neurol Sci; 1998 Feb; 155(1):1-12. PubMed ID: 9562316
[TBL] [Abstract][Full Text] [Related]
20. Induction of recurrent experimental allergic encephalomyelitis with myelin basic protein.
Panitch H; Ciccone C
Ann Neurol; 1981 May; 9(5):433-8. PubMed ID: 6168235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
